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Summary: A particle-enhanced immunoassay of ß2-microglobulin in serum is described. It is based on the
agglutination of complexes formed between the serum ß2-microglobulin and latex particles coated with F(ab')2
fragments of polyclonal anti-ß2-microglobulin antibodies. The analytical ränge of the method is 0.50 to
16 mg/1; it can be extended by appropriate dihition to 0.12 to 80 mg/1 with good precision (CV less than 5%
over the whole ränge). The accuracy and the precision are confirmed by a good correlation with radioim-
munoassay (n = 123, r = 0.993). No error due to antigen excess was observed, even up to 292 mg/1.
The main advantages of the method are its simplicity, its low cost per test and its high sensitivity (final
dilution of the sample at 1/1200) with no known interference. The calibration curve is stable for at least 2
weeks.
Introduction
ß2^Microglobulin is a low relative molecular mass
(l l 800) protein present on the membrane of almost
all nucleated cells, including lymphocytes, where it is
associated to the class I major histocompatibility an-
tigens (1). It is produced by the cells at a relatively
constant rate in healthy subjects, and it is released
into body fluids äs a result of cell turnover. Serum
ß2-microglobulin is freely filtered through the glo-
merular basement membrane of the kidney and reab-
sorbed by the proximal tübülar cells where it is ca-
tabolized, Serum ß2-microglobulin dfetermination is
useful in various cireumstances. Kidney rejection in
transplanted patients is correlated to the level of ß2-
microglobulin (2). In patients with multiple myeloma,
the serum ß2-microglobulin level is negatively corre-
lated with survival time. It is the best tuinour marker
in pure Bence-Jones myeloma and in some of the non-
secretory myeloinas (3). More recently, serum ß2-mi-
croglobulin has been described äs the most powerful
predictor of progression of HIV seropositive men to
AIDS over 3 years (4).
Different methods for ß2-microglobulin measurement
have already been described. They include radioim-
munoassay (5), radial immunodiffusion (6), direct im-
munoturbidimetry (7) or particle-enhanced turbidi-
metric immunoassay (PETIA) (8) and enzyme im-
munoassay (9). Most of these methods have one or
more drawbacks, such äs low sensitivity, high cost or
Potential interferences.
We describe here a particle-enhanced nephelometric
immunoassay for ß2-microglobulin which offers the
advantages of being sensitive, automated and inex-
pensive.
Materials and Methods
Apparatus
We used a Behring nephelomeler analyser (BNA) (Behring-
werke, Marburg, FRG) for all the delerminations.
Reagents and Standards
The buffer contains 0.1 mol/l glycinc, 0.17 mol/l NaCl, l g/l
bovine serum albumin (Cohn Fraction V, United States Bio-
Eur. J. Clin. Chem. CHn, Biochem. / Vol. 29,1991 / No. 6
402 Licvcns et al.: Immunonephelomctric measurcmcnt of ß2-microglobulin in serum
chemical Corporation, Clcvcland, USA) and 0.6 mmol/l sodium
azidc adjustcd to pH 9.2 with NaOH 8 mol/1. F(ab')2 fragments
of anti-pj-microglobulin IgG (reference A072, Dakopatts, Glos-
trup, Denmark) wcre prepared äs previously reported for the
preparation of anti-C-reactive protein F(ab')2 (10). Polystyrene
particles with a diameter of 0.24 (Estapor K58, Rhone-
Poiüenc, Courbevoie, France) were coated äs already described
(11). In the present case, a protein: latex weight ratio of l :5
was used. A working Suspension of l g/l of particles in the
buffer was used in the test. The particles can be frozen or freeze-
dried for long term conservation.
The Phadebas ß2-microglobulin RIA kits were obtained from
Pharmacia (Uppsala, Sweden).
A pool of serum was used äs Standard. Its ß2-microglobulin
concentration (3.24 mg/1) was determined by the RIA method
using the Standard of the Phadebas kit.
Methods
The latex reagent was vortexed before use. A six point calibra-
tion curve was obtained by automatic dilutions of the Standard
(1:80, 1:160, 1:320, 1:640, 1:1280 and 1:2560), giving a
concentration ränge from 0.5 to 16 mg/1.
The method settings are summarized in table l. The sample is
automatically prediluted to 1/400 with 0.15 mol/1 NaCl. Diluted
sample (70 ul) is mixed with 10 latex reagent and 140 0.15
mol/1 NaCl. The intensity of scattered light at 840 nm is meas-
ured after 10s and 12 min later. The difference between the
two Signals is converted into concentration by reference to a
calibration curve.
The RIA procedure was performed äs recommended by the
manufacturer.
Statistics
Regression parameters were calculated using a biometric regres-
sion procedure according to Passing & Bablok (12). The cali-
bration plot method (3 sy/x/slope) was used to determine the
lower limit of detection of the proposed method (13).
Results
Range and sensitivity
The calibration curve covers the ränge 0.50 to 16 mg/1
of ß2-microglobulin. If the concentration is higher
than 16 mg/1, the apparatus autpmatically dihites the
sample to 1/2000, raising the upper limit of the ränge
to 80 mg/1. If the concentration is lower than 0.5 mg/1,
the sample may be reprocessed at a lower dilution
(1/100 vs 1/400), decreasing the lower limit of the
ränge to 0.12 mg/1. The accuracy in the low ränge
remains good at the lowest tested concentration of
0.2 mg/1 (fig. 1). The detection limit calculated from
the results of the five experiments reported in figure
l ranged from 0.04 to 0.12 mg/1.
No error due to antigen excess was observed up to
292 mg/1, an unexpectedly high pathological concen-
tration of ßrmicroglobulin attained by forcing the
Instrument to perform the measurement on a serum
with a high ß2-micr oglobulin concentration (73 mg/1)
at a 1/100 dilution instead of 1/400 (fig. 2).
Accuracy and parallelism
ß2-Microglobulin was determined in 123 serum sam-
ples by RIA (x) and by the present method (y). Cor-
relation was excellent (r = 0.993) and the regression
equation was y = 1.03x +0.09 with means of
= 2.73 and y = 2.90 mg/1 (fig. 3). At the decision
level of 3 mg/1 (2), the random error (p = 0.95) is 0.17
mg/1 (14). Even without correction for a systematic
error (0.16 mg/1), the total error is lower than 0.4
mg/1, which is accepted äs an allowable error.
Tab. l. Settings of the immunoephelometric method for ß2-microglobulin naeasurement on the Behring Nephelometer Analyser.
Test name ß2-Microglobulin
Sample vol. [ ]
Reagent l vol. [ ]
Reagent 2 vol. [ ]
React. buffer vol. (1)
React. buffer vol. (2)
Measuring time [min]
Standard
No. of Standard points
First dilution
Deviation allowed [%]
-Validity [days]
Conc. unit
Measuring ränge [mg/1]
Lower level
Upper level
70
10
0
70
70
12
6
1:80.0
5.0
14
mg/1
0.47
15.00
Sample dilution
Minimal-dilution
B2M Latex
N Reaction Buffer
Fixed Time
B2M-15
1:400.0
1:100.0
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1/1600 1/800 1/400
Serum dilution
1/200
Fig. l. Linearity of the method in the low concentration ränge
(serial dilutions of 5 different sera).
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Fig. 2. Effect of high concentrations of ß2-microglobulin on the
signal of the nephelometer in the described method.
Dotted line: signal of the highest cälibration point be-
yond which the nephelometer asks for a rerun of the
sample at a higher dilution.
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Fig. 3. Comparison of ß2-microglobulin concentrations in 123
patient samples measured by RIA (x) and the irnmu-
nonephelometric method (y). The linear regression line
was y = 1.03x +· 0,09, r = 0.993.
To exclude any matrix effect or interference, we per-
formed serial dilutions of serum samples containing
a high concentration of ß2-microglobulin. All meas-
ured concentrations were within 0.75 mg/1 of the
expected values (ranging from l .4 to 34.0 mg/1), con-
firming the parallelism of the precipitation curves
obtained with the samples and with the serum pool
used äs Standard. N o systematic bias was observed
for lipaeinic or haemolysed samples.
Precision
curve
and stability of the cäl ibrat ion
Precision was evaluated on serum pools at 3 concen-
tration levels of ß2-microglobulin. The within-run pre-
cision was measured for 20 consecutive determina-
tions. The between-run precision was calculated from
the mean of 2 consecutive determinations per day
performed on 9 days over a period of 21 days. The
concentrations were calculated either from the cäli-
bration obtained on the first day, or from the curves
obtained on the day of the measurement. The results
are presented in table 2. The between-run precision is
better when the concentrations are calculated from
the same cälibration curve.
Tab. 2. Within-run and between-run reproducibility of the pro-
posed immunonephelometric method.
Within-run
Between-run first day
cälibration
every day
calibration
N
20
20
20
9
9
9
9
9
9
Mean
mg/1
1.53
4.42
8.58
2.73
5.96
9.71
1.90
4.70
9.29
CV
%
1.8
3.0
1.6
3.4
1.5
1.7
4.0
3.6
4.1
Three different frozen latex preparations were tested
for stability. For each preparation, either refrozen or
kept at 4 °C, the calibration curve was stable for at
least 15 days.
Effect of polyethyleneglycol
Polyethyleneglycol 6000 (6.7 mmol/1 or 4%) was
added to the reaction mixture in final concentrations
ranging from 0.2% to 1.15%. The sensitivity and the
precision of the calibration curve were not improved.
Therefore, polyethyleneglycol need not be added to
the reaction mixture.
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Discussion
The lower limit of deteclion of proteins by immuno-
nephelometry is in the ränge of l to 10 mg/1, depend-
ing on the affinity of the antibodies. By using these
antibodies to coat latex particles, the nephelometric
signal induced by the antigen-antibody reaction is
considerably enhanced. This is exemplified by the
present method, in which the sample is assayed at a
final dilution of 1/1200 and the final ß2-microglobulin
concentration is around l g/l. At such dilutions, tur-
bidity of the serum or haemolysis are no longer a
problem. This is an advantage over PETIA (8), which
is much less sensitive (final dilution of 1/100). More-
over, rheumatoid factor does not interfere, because
latex is coated with the F(ab')2 fraction of the specific
antibodies. The antibody used may originale from
any animal species. The only potential interference
that may occur comes from anti-F(ab')2 antibodies
present in exceptional cases. The stability of the cal-
ibration curve is satisfactory for at least two weeks,
although it does not display thp prolonged stability
of PETIA reagent.
The cost of the reagent is iricomparably lower than
any other method, only l antiserum being con-
sumed per test.
In conclusion, the present method for serum ß2-mi-
croglobulin determination is reliable, being sensitive
and free from interference. It is very suitable for
routine use, because it is inexpensive and can be
automated on a commonly used Instrument.
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